Logo image of CLDX

CELLDEX THERAPEUTICS INC (CLDX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:CLDX - US15117B2025 - Common Stock

25.83 USD
-1.19 (-4.4%)
Last: 12/1/2025, 12:45:53 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CLDX revenue by date.CLDX revenue by date.
2.36M
-49.25%
6.883M
191.65%
7.02M
1.99%
3.399M
-51.58%
3.131M
-7.88%
25.326M
708.88%
162.9M
543.21%
529.78M
225.22%
1.01B
90.65%
1.376B
36.24%
1.849B
34.38%
EBITDA
YoY % growth
CLDX ebitda by date.CLDX ebitda by date.
-97.33M
-50.50%
-139.034M
-42.85%
-191.901M
-38.02%
-256.565M
-33.70%
-294.386M
-14.74%
-329.029M
-11.77%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
CLDX ebit by date.CLDX ebit by date.
-100.23M
-47.96%
-142.042M
-41.72%
-195.078M
-37.34%
-260.814M
-33.70%
-303.314M
-16.30%
-320.728M
-5.74%
-246.3M
23.21%
14.958M
106.07%
377.19M
2,421.66%
737.28M
95.47%
1.123B
52.32%
Operating Margin
CLDX operating margin by date.CLDX operating margin by date.
-4,247.03%-2,063.66%-2,778.89%-7,673.25%-9,687.46%-1,266.40%-151.20%2.82%37.35%53.58%60.74%
EPS
YoY % growth
CLDX eps by date.CLDX eps by date.
-2.21
-34.76%
-2.91
-31.67%
-2.45
15.81%
-3.55
-45.05%
-4.24
-19.42%
-4.21
0.71%
-4.25
-0.82%
-1.36
68.07%
2.74
302.07%
7.58
176.65%
12.82
69.07%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-1.02
-43.56%
-1.09
-34.74%
-1.12
-31.37%
-1.16
-15.09%
-1.01
1.18%
Revenue
Q2Q % growth
1.618M
37.70%
665.04K
-4.31%
665.04K
-8.90%
767.04K849.997K
-47.47%
EBITDA
Q2Q % growth
-71.423M
-35.14%
-67.458M
-9.03%
-68.591M
-10.42%
-70.357M
0.98%
N/A
EBIT
Q2Q % growth
-75.328M
-34.45%
-77.939M
-24.23%
-79.354M
-24.27%
-80.833M
-9.80%
-79.798M
-5.93%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.01
-57.81%
-0.92-0.09-9.94%
Q2 2025
Q2Q % growth
-0.85
-57.41%
-0.870.022.62%
Q1 2025
Q2Q % growth
-0.81
-44.64%
-0.77-0.04-5.18%
Q4 2024
Q2Q % growth
-0.71
14.46%
-0.750.045.21%
Q3 2024
Q2Q % growth
-0.64
20.99%
-0.690.056.71%
Q2 2024
Q2Q % growth
-0.54
16.92%
-0.600.069.93%
Q1 2024
Q2Q % growth
-0.56
9.68%
-0.710.1520.89%
Q4 2023
Q2Q % growth
-0.83
-48.21%
-0.76-0.07-9.41%
Q3 2023
Q2Q % growth
-0.81
-42.11%
-0.69-0.12-17.03%
Q2 2023
Q2Q % growth
-0.65
-10.17%
-0.680.034.41%
Q1 2023
Q2Q % growth
-0.62
-26.53%
-0.640.023.82%
Q4 2022
Q2Q % growth
-0.56
-30.23%
-0.600.046.95%
Q3 2022
Q2Q % growth
-0.57
-26.67%
-0.590.023.09%
Q2 2022
Q2Q % growth
-0.59
-73.53%
-0.52-0.07-13.42%
Q1 2022
Q2Q % growth
-0.49
-16.67%
-0.46-0.03-5.81%
Q4 2021
Q2Q % growth
-0.43
21.82%
-0.430.00-1.18%
Q3 2021
Q2Q % growth
-0.45
-25.00%
-0.37-0.08-22.55%
Q2 2021
Q2Q % growth
-0.34
32.00%
-0.410.0716.67%
Q1 2021
Q2Q % growth
-0.42
42.47%
-0.39-0.03-8.36%
Q4 2020
Q2Q % growth
-0.55
14.06%
-0.37-0.18-47.06%
Q3 2020
Q2Q % growth
-0.36
52.00%
-0.370.011.96%
Q2 2020
Q2Q % growth
-0.50
40.48%
-0.590.0915.48%
Q1 2020
Q2Q % growth
-0.73
47.86%
-0.72-0.01-0.80%
Q4 2019
Q2Q % growth
-0.64 -0.920.2830.28%
Q3 2019
Q2Q % growth
-0.75 -0.860.1112.46%
Q2 2019
Q2Q % growth
-0.84 -1.190.3529.61%
Q1 2019
Q2Q % growth
-1.40 -1.16-0.24-20.40%
CLDX Yearly EPS VS EstimatesCLDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 -10 -20
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth

-100.00%
1.005M-1.005M-100.00%
Q2 2025
Q2Q % growth
730K
-70.78%
1.027M-297K-28.92%
Q1 2025
Q2Q % growth
695K
345.51%
1.067M-372K-34.86%
Q4 2024
Q2Q % growth
1.175M
-71.56%
1.138M37K3.25%
Q3 2024
Q2Q % growth
3.191M
110.35%
844.866K2.346M277.69%
Q2 2024
Q2Q % growth
2.498M
832.09%
836.839K1.661M198.50%
Q1 2024
Q2Q % growth
156K
-83.87%
934.065K-778.065K-83.30%
Q4 2023
Q2Q % growth
4.132M
156.65%
859.717K3.272M380.62%
Q3 2023
Q2Q % growth
1.517M
270.00%
586.837K930.163K158.50%
Q2 2023
Q2Q % growth
268K
67.50%
538.56K-270.56K-50.24%
Q1 2023
Q2Q % growth
967K
468.82%
418.2K548.8K131.23%
Q4 2022
Q2Q % growth
1.61M
387.88%
269.28K1.341M497.89%
Q3 2022
Q2Q % growth
410K
173.33%
367.2K42.8K11.66%
Q2 2022
Q2Q % growth
160K
-95.40%
408K-248K-60.78%
Q1 2022
Q2Q % growth
170K
-75.36%
571.2K-401.2K-70.24%
Q4 2021
Q2Q % growth
330K
-91.29%
1.057M-727K-68.78%
Q3 2021
Q2Q % growth
150K
-77.61%
1.246M-1.096M-87.96%
Q2 2021
Q2Q % growth
3.48M
1,350.00%
656.197K2.824M430.33%
Q1 2021
Q2Q % growth
690K
-74.73%
816K-126K-15.44%
Q4 2020
Q2Q % growth
3.79M
325.84%
612K3.178M519.28%
Q3 2020
Q2Q % growth
670K
21.82%
402.9K267.1K66.29%
Q2 2020
Q2Q % growth
240K
-66.67%
816K-576K-70.59%
Q1 2020
Q2Q % growth
2.73M
90.91%
1.01M1.72M170.30%
Q4 2019
Q2Q % growth
890K 831.3K58.7K7.06%
Q3 2019
Q2Q % growth
550K 1.285M-735K-57.20%
Q2 2019
Q2Q % growth
720K 1.285M-565K-43.97%
Q1 2019
Q2Q % growth
1.43M 1.255M175K13.94%
CLDX Yearly Revenue VS EstimatesCLDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-7.68% -8.16% 0% -0.25%
Revenue31.76% 11.43% -0.76% -13.4%